Skip to content
Catalyst

sodium(1+)What was measured

Measured, with no finding

971 endpoints

Show what was measuredHide what was measured
  • body composition

    no effect

    By day 14 there were once again no significant differences in body composition between the two groups

    PMID 10634837 · one of two readings recorded this

  • body water compartments

    no effect

    There were no significant differences between the groups in body water compartments on day 1

    PMID 10634837 · one of two readings recorded this

  • extracellular fluid volume

    decreases, p = 0.01

    By day 14 the delayed, but not the early group, also had a significant reduction in extracellular fluid volume (delayed -53 ml/kg, p=0.01; early -37 ml/kg, p=0.2)

    PMID 10634837 · one of two readings recorded this

  • extracellular fluid volume

    no effect, p = 0.2

    By day 14 the delayed, but not the early group, also had a significant reduction in extracellular fluid volume (delayed -53 ml/kg, p=0.01; early -37 ml/kg, p=0.2)

    PMID 10634837 · one of two readings recorded this

  • total body water

    decreases

    there was a significant loss of total body water during the first week (delayed -44 ml/kg, p=0. 048; early 6 ml/kg, p=0.970)

    PMID 10634837 · one of two readings recorded this

  • total body water

    no effect, p = 0.97

    there was a significant loss of total body water during the first week (delayed -44 ml/kg, p=0. 048; early 6 ml/kg, p=0.970)

    PMID 10634837 · one of two readings recorded this

  • total body weight (body composition)

    modulates, p = 0.013

    These changes resulted in a significant alteration in body composition at the end of the first week (total body weight: delayed 791 ml/kg; early 849 ml/kg, p=0.013)

    PMID 10634837 · one of two readings recorded this

  • peak power over eight 15-s intervals of maximal effort arm ergometry, with total work and percent fatigue

    no effect, peak power 370.7, 346.3 and 354.3 W across the three treatments, described as similar

    Not recorded as a finding: a node exists but the paper states a different instrument or population

    However, peak power (370.7 +/- 26.0, 346.3 +/- 13.6, and 354.3 +/- 18.9 W) and total work accomplished in eight intervals (30.2 +/- 1.5, 29.6 +/- 1.1, and 29.9 +/- 1.1 kJ), and percent fatigue (31.0 +/- 2.7, 29.0 +/- 3.2, and 29.2 +/- 4.0%) were similar.

    PMID 10731011 · one of two readings recorded this

  • peak power

    no effect, n = 8

    peak power (370.7 +/- 26.0, 346.3 +/- 13.6, and 354.3 +/- 18.9 W)

    PMID 10731011 · one of two readings recorded this

  • percent fatigue

    no effect, n = 8

    percent fatigue (31.0 +/- 2.7, 29.0 +/- 3.2, and 29.2 +/- 4.0%)

    PMID 10731011 · one of two readings recorded this

  • postexercise base excess

    increases, n = 8

    Postexercise pH (7.02 +/- 0.01, 7.02 +/- 0.03, and 7.09 +/- 0.03) and base excess (-13.29 +/- 0.96, -14.49 +/- 1.01, and -8.83 +/- 1.38) were significantly lower after both PC and NaCl ingestion compared with NaHCO3 ingestion

    PMID 10731011 · one of two readings recorded this

  • postexercise plasma lactate

    unclear, n = 8

    Postexercise plasma [lactate] was also greater in both PC and NaHCO3 trials (21.42 +/- 1.52, 20.07 +/- 1.39, and 22.65 +/- 1.77 mmol x L(-1))

    PMID 10731011 · one of two readings recorded this

  • postexercise venous pH

    increases, n = 8

    Postexercise pH (7.02 +/- 0.01, 7.02 +/- 0.03, and 7.09 +/- 0.03) and base excess (-13.29 +/- 0.96, -14.49 +/- 1.01, and -8.83 +/- 1.38) were significantly lower after both PC and NaCl ingestion compared with NaHCO3 ingestion

    PMID 10731011 · one of two readings recorded this

  • preexercise base excess

    increases, p = 0.05, n = 8

    Preexercise pH (7.33 +/- 0.01, 7.31 +/- 0.01, and 7.40 +/- 0.01) and base excess (2.41 +/- 0.35, 0.93 +/- 0.39, and 8.45 +/- 0.51) after PC and NaCl ingestion, respectively, were similar, whereas ingestion of NaHCO3 resulted in significantly higher values (P < or = 0.05)

    PMID 10731011 · one of two readings recorded this

  • preexercise venous pH

    increases, p = 0.05, n = 8

    Preexercise pH (7.33 +/- 0.01, 7.31 +/- 0.01, and 7.40 +/- 0.01) and base excess (2.41 +/- 0.35, 0.93 +/- 0.39, and 8.45 +/- 0.51) after PC and NaCl ingestion, respectively, were similar, whereas ingestion of NaHCO3 resulted in significantly higher values (P < or = 0.05)

    PMID 10731011 · one of two readings recorded this

  • total work accomplished in eight intervals

    no effect, n = 8

    total work accomplished in eight intervals (30.2 +/- 1.5, 29.6 +/- 1.1, and 29.9 +/- 1.1 kJ)

    PMID 10731011 · one of two readings recorded this

  • pulmonary artery pressure estimated by echocardiographic ratio of time to peak velocity to right ventricular ejection time corrected for heart rate (TPV:RVET(c)), sodium 4 mmol/kg/day started 24 hours after birth versus started at 6% weight loss; abstract only

    no effect

    Not recorded as a finding: the comparison was against another active treatment

    There was no difference between the two groups in TPV:RVET(c) measured sequentially after birth.

    PMID 11420318 · one of two readings recorded this

  • pulmonary artery pressure estimated by echocardiographic ratio of time to peak velocity to right ventricular ejection time corrected for heart rate (TPV:RVETc), days 0, 1, 2, 7 and 14

    no effect

    Not recorded as a finding: the comparison was against another active treatment

    There was no difference between the two groups in TPV:RVET(c) measured sequentially after birth.

    PMID 11420318 · one of two readings recorded this

  • TPV:RVET(c) ratio, early versus delayed supplementation

    no effect

    There was no difference between the two groups in TPV:RVET(c) measured sequentially after birth

    PMID 11420318 · one of two readings recorded this

  • TPV:RVET(c) ratio versus value at birth

    increases

    in whom a significant fall did not occur until day 14

    PMID 11420318 · one of two readings recorded this

  • TPV:RVET(c) ratio versus value at birth

    increases

    On within group testing, when compared with values at birth, the ratio was higher by day 3 in the early supplemented group

    PMID 11420318 · one of two readings recorded this

  • total glycemic response, area under the glucose curve in a 75-g oral glucose tolerance test

    decreases, 8.0% lower during sodium supplementation

    Not recorded as a finding: the paper never states the instrument the node requires

    Total glycemic response in the oral GTT (area under the glucose curve) was 8.0% lower during sodium supplementation, P < .001.

    PMID 11465650 · one of two readings recorded this

  • total glycemic response in oral GTT (area under the glucose curve)

    decreases, p = 0.001, n = 21

    Total glycemic response in the oral GTT (area under the glucose curve) was 8.0% lower during sodium supplementation, P < .001

    PMID 11465650 · one of two readings recorded this

  • total glycemic response in oral GTT (area under the glucose curve)

    decreases, n = 6

    the effect of sodium was noteworthy in 1) type 2 diabetic subjects (n = 8), 2) sodium-sensitive subjects (n = 10), and 3) nondiabetic subjects receiving antihypertensive drug treatment (n = 6)

    PMID 11465650 · one of two readings recorded this

  • total glycemic response in oral GTT (area under the glucose curve)

    decreases, n = 10

    the effect of sodium was noteworthy in 1) type 2 diabetic subjects (n = 8), 2) sodium-sensitive subjects (n = 10), and 3) nondiabetic subjects receiving antihypertensive drug treatment (n = 6)

    PMID 11465650 · one of two readings recorded this

  • total glycemic response in oral GTT (area under the glucose curve)

    decreases, n = 8

    the effect of sodium was noteworthy in 1) type 2 diabetic subjects (n = 8), 2) sodium-sensitive subjects (n = 10), and 3) nondiabetic subjects receiving antihypertensive drug treatment (n = 6)

    PMID 11465650 · one of two readings recorded this

  • total glycemic response in the 75-g oral glucose tolerance test, area under the glucose curve

    decreases, 8.0% lower during sodium supplementation

    Not recorded as a finding: the paper never states the instrument the node requires

    Total glycemic response in the oral GTT (area under the glucose curve) was 8.0% lower during sodium supplementation, P < .001.

    PMID 11465650 · one of two readings recorded this

  • total insulinemic response to oral GTT

    decreases

    The total insulinemic response to oral GTT was also lowered by sodium loading among diabetic subjects

    PMID 11465650 · one of two readings recorded this

  • urinary sodium excretion

    increases, p = 0.001, n = 21

    urinary sodium excretion increased on sodium chloride to 267+/-118 mEq/day versus control (placebo) phase of 135+/-53 mEq/day, P < .001

    PMID 11465650 · one of two readings recorded this

  • change in plasma sodium concentration over a 4 h run, replacement fluid at 680 mg/l sodium (H) or 410 mg/l (L) versus water only (W), 1 litre per hour; abstract only

    mean decrease in plasma sodium 2.5 (2.5) mmol/l in H vs 6.2 (2.1) mmol/l in W, n = 13

    Not recorded as a finding: the direction is carried only as a signed number

    The mean (SD) decrease in [Na(+)](plasma) over the whole trial was significantly (p<0.001) less in trial H (2.5 (2.5) mmol/l) than in trial W (6.2 (2.1) mmol/l).

    PMID 12893712 · one of two readings recorded this

  • correlation between changes in plasma sodium and changes in body weight

    increases

    There was a significant correlation between changes in [Na(+)](plasma) and changes in body weight

    PMID 12893712 · one of two readings recorded this

  • correlation between plasma sodium after the run and performance

    no effect

    There was no significant correlation between[Na(+)](plasma) after the run and performance

    PMID 12893712 · one of two readings recorded this

  • decrease in plasma sodium over the whole trial

    decreases, p = 0.001

    The mean (SD) decrease in [Na(+)](plasma) over the whole trial was significantly (p<0.001) less in trial H (2.5 (2.5) mmol/l) than in trial W (6.2 (2.1) mmol/l)

    PMID 12893712 · one of two readings recorded this

  • performance and haematological variables

    no effect

    No significant differences were found in performance or haematological variables with the three different fluids

    PMID 12893712 · one of two readings recorded this

  • plasma sodium concentration change over a 4-hour run with fluid of 680 mg/l, 410 mg/l or water only; also packed cell volume, mean corpuscular volume, endurance performance

    mean decrease in plasma sodium 2.5 (2.5) mmol/l in trial H versus 6.2 (2.1) mmol/l in trial W, p = 0.001

    Not recorded as a finding: the direction is carried only as a signed number

    The mean (SD) decrease in [Na(+)](plasma) over the whole trial was significantly (p<0.001) less in trial H (2.5 (2.5) mmol/l) than in trial W (6.2 (2.1) mmol/l).

    PMID 12893712 · one of two readings recorded this

  • growth rate

    unclear, p = 0.01

    a significant difference in growth rate (P < 0.01) observed between the two groups

    PMID 1298620 · one of two readings recorded this

  • osteoblastic activity and protein synthesis

    increases

    Both groups had increased levels of osteoblastic activity accompanied by high rate of protein synthesis in the supplemented group compared to the non-supplemented one

    PMID 1298620 · one of two readings recorded this

  • serum calcium

    decreases, significantly higher in the non-supplemented group

    Not recorded as a finding: no outcome node for serum calcium

    Results indicated significantly increased serum levels of calcium (P < 0.01) in the non-supplemented group while inorganic phosphate and total protein levels showed significant increase (P < 0.05) in the supplemented group.

    PMID 1298620 · one of two readings recorded this

  • serum calcium

    decreases, p = 0.01

    Results indicated significantly increased serum levels of calcium (P < 0.01) in the non-supplemented group

    PMID 1298620 · one of two readings recorded this

  • serum inorganic phosphate, serum calcium, total protein, albumin and alkaline phosphatase in VLBW infants supplemented with 3 mMol/kg/day sodium chloride for six weeks versus unsupplemented; direction of the phosphate comparison cannot be told to be between-group or within-group

    increases, significant increase in the supplemented group

    Not recorded as a finding: another reason, stated per paper

    Results indicated significantly increased serum levels of calcium (P < 0.01) in the non-supplemented group while inorganic phosphate and total protein levels showed significant increase (P < 0.05) in the supplemented group.

    PMID 1298620 · one of two readings recorded this

  • serum inorganic phosphate

    increases, p = 0.05

    while inorganic phosphate and total protein levels showed significant increase (P < 0.05) in the supplemented group

    PMID 1298620 · one of two readings recorded this

  • serum total protein

    increases, significant increase in the supplemented group

    Not recorded as a finding: no outcome node for serum total protein

    Results indicated significantly increased serum levels of calcium (P < 0.01) in the non-supplemented group while inorganic phosphate and total protein levels showed significant increase (P < 0.05) in the supplemented group.

    PMID 1298620 · one of two readings recorded this

  • serum total protein

    increases, p = 0.05

    while inorganic phosphate and total protein levels showed significant increase (P < 0.05) in the supplemented group

    PMID 1298620 · one of two readings recorded this

  • serum potassium concentration

    no effect

    while sodium and potassium concentrations were not significantly affected

    PMID 1473517 · one of two readings recorded this

  • serum sodium concentration

    no effect

    while sodium and potassium concentrations were not significantly affected

    PMID 1473517 · one of two readings recorded this

  • head circumference gain

    increases

    Determination of weight gain, length gain and head circumference gain showed that these anthropometric parameters are significantly increased by sodium supplementation

    PMID 1473517 · one of two readings recorded this

  • length gain

    increases

    Determination of weight gain, length gain and head circumference gain showed that these anthropometric parameters are significantly increased by sodium supplementation

    PMID 1473517 · one of two readings recorded this

  • renal excretion of sodium

    increases

    There were no cases of either hypernatraemia or hyponatraemia though renal excretion of sodium was very high in the supplemented group

    PMID 1473517 · one of two readings recorded this

  • weight gain, length gain and head circumference gain over six weeks in VLBW infants fed own mothers milk; serum and urinary sodium and potassium

    increases, significantly increased by sodium supplementation

    Not recorded as a finding: a node exists but the paper states a different instrument or population

    Determination of weight gain, length gain and head circumference gain showed that these anthropometric parameters are significantly increased by sodium supplementation while sodium and potassium concentrations were not significantly affected.

    PMID 1473517 · one of two readings recorded this

  • weight gain, length gain and head circumference gain over six weeks; sodium and potassium concentrations (serum and urinary, matrix not separated in the sentence)

    increases, anthropometric parameters significantly increased by sodium supplementation

    Not recorded as a finding: a node exists but the paper states a different instrument or population

    Determination of weight gain, length gain and head circumference gain showed that these anthropometric parameters are significantly increased by sodium supplementation while sodium and potassium concentrations were not significantly affected.

    PMID 1473517 · one of two readings recorded this

  • weight gain

    increases

    Determination of weight gain, length gain and head circumference gain showed that these anthropometric parameters are significantly increased by sodium supplementation

    PMID 1473517 · one of two readings recorded this

  • 15-min performance time trial following cycling at 70% of maximal work rate

    increases, approximately 7.8% improvement in time trial performance

    Not recorded as a finding: a node exists but the paper states a different instrument or population

    There was a significant improvement ( approximately 7.8 %; p < 0.05) in time trial performance following IPOSL.

    PMID 15776333 · one of two readings recorded this

  • core temperature

    no effect, p = 0.05

    No significant differences were observed for heart rate, core temperature, rate of perceived exertion or total body sweat rate (p > 0.05)

    PMID 15776333 · one of two readings recorded this

  • heart rate

    no effect, p = 0.05

    No significant differences were observed for heart rate, core temperature, rate of perceived exertion or total body sweat rate (p > 0.05)

    PMID 15776333 · one of two readings recorded this

  • performance time trial following a 15-min performance time trial after 45 min cycling at 70% of maximal work rate

    increases, approximately 7.8% improvement

    Not recorded as a finding: a node exists but the paper states a different instrument or population

    There was a significant improvement ( approximately 7.8 %; p < 0.05) in time trial performance following IPOSL.

    PMID 15776333 · one of two readings recorded this

  • plasma volume during exercise

    increases

    IPOSL maintained plasma volume during exercise to a greater extent than the Pl at 15 and 30, but not 45 min

    PMID 15776333 · one of two readings recorded this

  • plasma volume during exercise

    increases

    IPOSL maintained plasma volume during exercise to a greater extent than the Pl at 15 and 30, but not 45 min

    PMID 15776333 · one of two readings recorded this

  • plasma volume during exercise

    no effect

    IPOSL maintained plasma volume during exercise to a greater extent than the Pl at 15 and 30, but not 45 min

    PMID 15776333 · one of two readings recorded this

  • rate of perceived exertion

    no effect, p = 0.05

    No significant differences were observed for heart rate, core temperature, rate of perceived exertion or total body sweat rate (p > 0.05)

    PMID 15776333 · one of two readings recorded this

  • resting baseline plasma volume change

    increases

    IPOSL and Pl ingestion lead to a 3.1 % expansion and a 4.7 % reduction in resting baseline plasma volume, respectively

    PMID 15776333 · one of two readings recorded this

  • resting baseline plasma volume change

    decreases

    IPOSL and Pl ingestion lead to a 3.1 % expansion and a 4.7 % reduction in resting baseline plasma volume, respectively

    PMID 15776333 · one of two readings recorded this

  • time trial performance

    increases, p = 0.05

    There was a significant improvement ( approximately 7.8 %; p < 0.05) in time trial performance following IPOSL

    PMID 15776333 · one of two readings recorded this

  • total body sweat rate

    no effect, p = 0.05

    No significant differences were observed for heart rate, core temperature, rate of perceived exertion or total body sweat rate (p > 0.05)

    PMID 15776333 · one of two readings recorded this

  • 24 hour urine sodium

    n = 17

    The mean (SD) urine sodium was 147 (45), 84 (32), and 201 (73) mmol/24 hours in the normal, low, and high sodium intake periods respectively

    PMID 1609379 · one of two readings recorded this

  • 24 hour urine sodium

    n = 17

    The mean (SD) urine sodium was 147 (45), 84 (32), and 201 (73) mmol/24 hours in the normal, low, and high sodium intake periods respectively

    PMID 1609379 · one of two readings recorded this

  • 24 hour urine sodium

    n = 17

    The mean (SD) urine sodium was 147 (45), 84 (32), and 201 (73) mmol/24 hours in the normal, low, and high sodium intake periods respectively

    PMID 1609379 · one of two readings recorded this

  • peak expiratory flow (PEF) and PEF amplitude (highest minus lowest PEF), patient home measurements, across normal, low and high dietary sodium for two weeks

    no effect, no significant differences in PEF or PEF amplitude between the three dietary salt periods

    Not recorded as a finding: this platform holds no node for the endpoint

    There were no significant differences in PEF or PEF amplitude (highest--lowest PEF), an index of asthma lability, between the three dietary salt periods.

    PMID 1609379 · one of two readings recorded this

  • peak expiratory flow (PEF) and PEF amplitude, home measurement by patients, over normal, low and high dietary sodium periods

    no effect, no significant differences between the three dietary salt periods

    Not recorded as a finding: this platform holds no node for the endpoint

    There were no significant differences in PEF or PEF amplitude (highest--lowest PEF), an index of asthma lability, between the three dietary salt periods.

    PMID 1609379 · one of two readings recorded this

  • peak expiratory flow (PEF) and PEF amplitude

    no effect, n = 17

    There were no significant differences in PEF or PEF amplitude (highest--lowest PEF), an index of asthma lability, between the three dietary salt periods

    PMID 1609379 · one of two readings recorded this

  • additional sodium ingested during the race

    Subjects in the sodium supplementation group ingested an additional 3.6 (2.0) g (156 (88) mmol) sodium during the race

    PMID 16505084 · one of two readings recorded this

  • tablets consumed

    no effect, p = 0.55

    The sodium supplementation group consumed 14.7 (8.3) tablets, and the placebo group took 15.8 (10.1) tablets (p = 0.55; NS)

    PMID 16505084 · one of two readings recorded this

  • area under the curve for systolic blood pressure over 30 and 60 minutes after ingestion of salt water versus water, noninvasive BP, seated

    decreases, SBP AUC at 30 minutes 364 with NaCl-H2O versus 714 mm Hg x min with H2O

    Not recorded as a finding: a node exists but the paper states a different instrument or population

    The area under the curve for SBP was greater with H2O than NaCl-H2O for the 30 minutes (714+/-388 mm Hg x min versus 364+/-369 mm Hg x min; P = 0.002) and 60 minutes (1454+/-827 mm Hg x min versus 812+/-734 mm Hg x min; P = 0.048) after ingestion.

    PMID 16785332 · one of two readings recorded this

  • area under the curve for systolic blood pressure

    decreases, p = 0.002

    The area under the curve for SBP was greater with H2O than NaCl-H2O for the 30 minutes (714+/-388 mm Hg x min versus 364+/-369 mm Hg x min; P = 0.002)

    PMID 16785332 · one of two readings recorded this

  • area under the curve for systolic blood pressure

    decreases, p = 0.048

    and 60 minutes (1454+/-827 mm Hg x min versus 812+/-734 mm Hg x min; P = 0.048)

    PMID 16785332 · one of two readings recorded this

  • increase in systolic blood pressure

    decreases, p = 0.006

    The increase in SBP with H2O was greater than with NaCl-H2O at 30 minutes (37+/-6 versus 18+/-5 mm Hg; P = 0.006)

    PMID 16785332 · one of two readings recorded this

  • increase in systolic blood pressure

    no effect, p = 0.4

    but not at 60 minutes (17+/-6 versus 10+/-6 mm Hg; P = 0.4)

    PMID 16785332 · one of two readings recorded this

  • norepinephrine

    no effect, p = 0.195

    Norepinephrine increased after H2O (P = 0.018) but not after NaCl-H2O (P = 0.195)

    PMID 16785332 · one of two readings recorded this

  • norepinephrine

    increases, p = 0.018

    Norepinephrine increased after H2O (P = 0.018) but not after NaCl-H2O (P = 0.195)

    PMID 16785332 · one of two readings recorded this

  • body mass loss before rehydration

    decreases

    eight males lost 1.98 +/- 0.1% body mass exercising in the heat

    PMID 18463891 · one of two readings recorded this

  • time to exhaustion at 95% VO2peak after a 5 min bout at 70% VO2peak, 4 h after rehydration with drinks of 1, 31, 40 or 50 mmol/l sodium chloride

    no effect, time to exhaustion not different between treatments, p = 0.883

    Not recorded as a finding: the comparison was against another active treatment

    Time to exhaustion in the exercise capacity test was not different between treatments (P = 0.883).

    PMID 18463891 · one of two readings recorded this

  • time to exhaustion at 95% VO2peak

    no effect, p = 0.883, n = 8

    Time to exhaustion in the exercise capacity test was not different between treatments (P = 0.883)

    PMID 18463891 · one of two readings recorded this

  • time to exhaustion cycling at 95% VO2peak after 5 min at 70% VO2peak, 4 h after rehydration with drinks of 1, 31, 40 or 50 mmol/l sodium chloride; urine output

    no effect, time to exhaustion not different between treatments, p = 0.883

    Not recorded as a finding: the comparison was against another active treatment

    Time to exhaustion in the exercise capacity test was not different between treatments (P = 0.883).

    PMID 18463891 · one of two readings recorded this

  • urine output, 1 mmol/l drink versus 40 and 50 mmol/l drinks

    decreases, p = 0.01, n = 8

    more was produced with the 1 than the 40 and 50 mmol/l drinks (P < 0.01)

    PMID 18463891 · one of two readings recorded this

  • blood pressure difference per difference in salt intake (INTERSALT)

    increases

    The population study identified a minimal impact of sodium intake on blood pressure (0.9 mm Hg/10 mmol difference in salt intake)

    PMID 19121772 · one of two readings recorded this

  • cardiovascular events (TONE)

    decreases

    Cardiovascular events were highest in the usual care group (83%) and lowest in the sodium reduction-plus-weight loss group (56%)

    PMID 19121772 · one of two readings recorded this

  • cardiovascular events (TONE)

    Cardiovascular events were highest in the usual care group (83%) and lowest in the sodium reduction-plus-weight loss group (56%)

    PMID 19121772 · one of two readings recorded this

  • median systolic blood pressure (meta-analysis of 11 long-term trials)

    decreases

    A systematic review of 11 long-term controlled randomized trials reported a small decrease (1.1 mm Hg) in median systolic but not diastolic blood pressure with a reduced dietary sodium intake

    PMID 19121772 · one of two readings recorded this

  • Muscle cramping frequency

    no effect, n = 13

    None of the volunteers experienced cramping

    PMID 19295955 · one of two readings recorded this

  • Plasma osmolality

    decreases, p = 0.05, n = 13

    The same trends were observed for plasma osmolality (P < .05)

    PMID 19295955 · one of two readings recorded this

  • Plasma volume change

    decreases, n = 13

    Albeit not significant, plasma volume was preserved during the HNa and LNa trials, but a reduction of 2.5% was observed in the W and PL trials

    PMID 19295955 · one of two readings recorded this

  • Plasma volume change

    decreases, n = 13

    Albeit not significant, plasma volume was preserved during the HNa and LNa trials, but a reduction of 2.5% was observed in the W and PL trials

    PMID 19295955 · one of two readings recorded this

  • Serum sodium concentration at end of protocol

    no effect, n = 13

    serum sodium concentration at the end of the protocol was 137.3 mmol/L and 136.7 mmol/L, respectively

    PMID 19295955 · one of two readings recorded this

  • Serum sodium concentration at end of protocol

    no effect, n = 13

    serum sodium concentration at the end of the protocol was 137.3 mmol/L and 136.7 mmol/L, respectively

    PMID 19295955 · one of two readings recorded this

  • Serum sodium concentration at end of protocol

    decreases, p = 0.05, n = 13

    a clear decrease was observed in W (134.5 +/- 0.8 mmol/L) and PL (134.4 +/- 0.8 mmol/L) trials compared with HNa and LNa trials (P < .05)

    PMID 19295955 · one of two readings recorded this

  • Serum sodium concentration at end of protocol

    decreases, p = 0.05, n = 13

    a clear decrease was observed in W (134.5 +/- 0.8 mmol/L) and PL (134.4 +/- 0.8 mmol/L) trials compared with HNa and LNa trials (P < .05)

    PMID 19295955 · one of two readings recorded this

  • serum sodium concentration at the end of 3 h exercise in the heat plus calf-raise and steep walking, carbohydrate-electrolyte drinks at 36.2 and 19.9 mmol/L sodium versus mineral water and coloured flavoured distilled water

    increases, n = 13

    Not recorded as a finding: the intervention held more than the compound

    However, a clear decrease was observed in W (134.5 +/- 0.8 mmol/L) and PL (134.4 +/- 0.8 mmol/L) trials compared with HNa and LNa trials (P < .05).

    PMID 19295955 · one of two readings recorded this

  • serum sodium concentration at the end of 3 h exercise in the heat with calf-raise and steep-walk protocol; plasma osmolality, plasma volume, cramping frequency

    no effect

    Not recorded as a finding: the intervention held more than the compound

    During both HNa and LNa trials, serum sodium remained relatively constant (serum sodium concentration at the end of the protocol was 137.3 mmol/L and 136.7 mmol/L, respectively).

    PMID 19295955 · one of two readings recorded this

  • pulse wave analysis, systolic and diastolic blood pressure

    no effect

    There was also no change in pulse wave analysis, systolic or diastolic blood pressure between interventions

    PMID 22171802 · one of two readings recorded this

  • pulse wave velocity (PWV); also pulse wave analysis, systolic and diastolic blood pressure, after 4 weeks of sodium-free (A), 90 mmol Na (B) or 140 mmol Na (C) tomato juice on a 60 mmol/day low-sodium diet

    no effect, PWV B-A 0.00 m/s (95% CI -0.30, 0.31); C-A 0.01 m/s (95% CI -0.38, 0.40)

    Not recorded as a finding: the supporting sentence never names the compound

    There was no difference in PWV between interventions (B-A 0.00 m/s, 95% CI: -0.30, 0.31 m/s; C-A 0.01 m/s, 95% CI: -0.38, 0.40 m/s).

    PMID 22171802 · one of two readings recorded this

  • pulse wave velocity (PWV), segment and device not stated, after sodium-free versus 90 and 140 mmol Na tomato juice for 4 weeks

    no effect, B-A 0.00 m/s (95% CI -0.30, 0.31); C-A 0.01 m/s (95% CI -0.38, 0.40)

    Not recorded as a finding: the supporting sentence never names the compound

    There was no difference in PWV between interventions (B-A 0.00 m/s, 95% CI: -0.30, 0.31 m/s; C-A 0.01 m/s, 95% CI: -0.38, 0.40 m/s).

    PMID 22171802 · one of two readings recorded this

  • pulse wave velocity

    no effect, n = 23

    There was no difference in PWV between interventions (B-A 0.00 m/s, 95% CI: -0.30, 0.31 m/s; C-A 0.01 m/s, 95% CI: -0.38, 0.40 m/s)

    PMID 22171802 · one of two readings recorded this

  • pulse wave velocity

    no effect, n = 23

    There was no difference in PWV between interventions (B-A 0.00 m/s, 95% CI: -0.30, 0.31 m/s; C-A 0.01 m/s, 95% CI: -0.38, 0.40 m/s)

    PMID 22171802 · one of two readings recorded this

  • urinary sodium excretion

    increases

    There was an appropriate increase in urinary sodium excretion in the added sodium interventions

    PMID 22171802 · one of two readings recorded this

  • 24 h mean blood pressure (salt resistance check)

    no effect, p = 0.05, n = 12

    LS: 84 ± 1 mmHg vs. HS: 85 ± 2 mmHg; P > 0.05

    PMID 22907057 · one of two readings recorded this

  • cutaneous microvascular function, plateau percent of maximal cutaneous vascular conductance during local heating by laser Doppler flowmetry, 7-day high-sodium (350 mmol/day) versus 7-day low-sodium (20 mmol/day) controlled diet

    decreases, plateau %CVCmax LS 93 +/- 1 vs HS 80 +/- 2, n = 12

    Not recorded as a finding: the comparison was against another active treatment

    The plateau % CVCmax was reduced during HS (LS: 93 ± 1 % CVCmax vs. HS: 80 ± 2 % CVCmax; P < 0.05).

    PMID 22907057 · one of two readings recorded this

  • cutaneous microvascular function, plateau percent of maximal cutaneous vascular conductance during local heating to 42 C, laser Doppler flowmetry with microdialysis

    decreases, plateau % CVCmax 93 +/- 1 on low sodium versus 80 +/- 2 on high sodium

    Not recorded as a finding: this platform holds no node for the endpoint

    The plateau % CVCmax was reduced during HS (LS: 93 ± 1 % CVCmax vs. HS: 80 ± 2 % CVCmax; P < 0.05).

    PMID 22907057 · one of two readings recorded this

  • Nitric oxide contribution to vasodilatation (L-NAME), ascorbic acid vs Ringer

    increases, p = 0.05, n = 12

    restored the NO contribution (Ringer: 44 ± 3 % CVCmax vs. AA: 59 ± 6 % CVCmax; P < 0.05)

    PMID 22907057 · one of two readings recorded this

  • Plateau cutaneous vascular conductance during local heating, ascorbic acid vs Ringer

    increases, p = 0.05, n = 12

    During the HS diet, AA improved the plateau % CVCmax (Ringer: 80 ± 2 % CVCmax vs. AA: 89 ± 3 % CVCmax; P < 0.05)

    PMID 22907057 · one of two readings recorded this

  • Plateau cutaneous vascular conductance during local heating (Ringer site)

    decreases, p = 0.05, n = 12

    The plateau % CVCmax was reduced during HS (LS: 93 ± 1 % CVCmax vs. HS: 80 ± 2 % CVCmax; P < 0.05)

    PMID 22907057 · one of two readings recorded this

  • Sodium excretion

    increases, p = 0.05, n = 12

    Sodium excretion increased during the HS diet (P < 0.05)

    PMID 22907057 · one of two readings recorded this

  • HDL cholesterol

    no effect

    High density lipoprotein cholesterol cholesterol (mmol/L) | 9 | 2031 | 0 | −0.01 (−0.03 to 0.00)

    PMID 23558163 · one of two readings recorded this

  • LDL cholesterol

    no effect

    Low density lipoprotein cholesterol (mmol/L) | 6 | 1909 | 0 | 0.03 (−0.02 to 0.08)

    PMID 23558163 · one of two readings recorded this

  • triglyceride

    no effect

    Triglyceride (mmol/L) | 8 | 2049 | 0 | 0.04 (−0.04 to 0.09)

    PMID 23558163 · one of two readings recorded this

  • all cause mortality, cohort studies, higher sodium intake

    unclear

    Not recorded as a finding: paper calls the result inconclusive, which is not a two-sided statement of no effect; follow-up horizon not stated in the sentence

    The meta-analysis of seven studies with 10 comparisons reporting all cause mortality was inconclusive (risk ratio 1.06, 0.94 to 1.20) (table 3).

    PMID 23558163 · one of two readings recorded this

  • all cause mortality, cohort studies, highest versus lowest sodium intake

    RR 1.06 (0.94 to 1.20)

    Not recorded as a finding: paper states the result is 'inconclusive' (RR 1.06, 0.94 to 1.20), which is neither a direction nor an absence of effect

    The meta-analysis of seven studies with 10 comparisons reporting all cause mortality was inconclusive (risk ratio 1.06, 0.94 to 1.20) (table 3).

    PMID 23558163 · one of two readings recorded this

  • all cause mortality

    no effect

    All cause mortality21 22 96 97 100 101 106 | 7 | 21 515 | 61 | 1.06 (0.94 to 1.20)

    PMID 23558163 · one of two readings recorded this

  • cardiovascular disease, all events

    no effect

    All events‡21 22 94 96 100 101 106 107 | 9 | 46 483 | 78 | 1.12 (0.93 to 1.34)

    PMID 23558163 · one of two readings recorded this

  • cardiovascular disease, combined fatal and non-fatal events

    no effect

    Combined fatal and non-fatal events§21 22 94 97 | 4 | 8698 | 77 | 1.08 (0.78 to 1.47)

    PMID 23558163 · one of two readings recorded this

  • cardiovascular disease, fatal events

    no effect

    Fatal events21 22 96 100 101 106 107 | 7 | 41 881 | 80 | 1.08 (0.87 to 1.33)

    PMID 23558163 · one of two readings recorded this

  • cardiovascular events (randomised controlled trials)

    no effect

    (risk ratio 0.84, 95% confidence interval 0.57 to 1.23)

    PMID 23558163 · one of two readings recorded this

  • coronary heart disease, all events

    no effect

    All events22 94 100 101 106 107 | 6 | 37 343 | 68 | 1.04 (0.86 to 1.24)

    PMID 23558163 · one of two readings recorded this

  • coronary heart disease, combined fatal and non-fatal events

    no effect

    Combined fatal and non-fatal events22 94 100 101 106 | 5 | 13 851 | 72 | 1.02 (0.83 to 1.24)

    PMID 23558163 · one of two readings recorded this

  • coronary heart disease, fatal events

    increases

    Fatal events101 106 107 | 3 | 30 670 | 0 | 1.32 (1.13 to 1.53)

    PMID 23558163 · one of two readings recorded this

  • creatinine clearance

    no effect

    Creatinine clearance (mL/min) | 2 | 232 | 0 | −7.67 (−16.17 to 0.83)

    PMID 23558163 · one of two readings recorded this

  • fatal coronary heart disease events, cohort studies, higher sodium intake

    increases

    Not recorded as a finding: fatal-only coronary events do not match the coronary-heart-disease-incidence node (fatal and non-fatal events)

    The meta-analysis of three studies with five comparisons of sodium intake and coronary heart disease mortality detected an increased risk of fatal coronary heart disease events with higher sodium intake (1.32, 1.13 to 1.53).

    PMID 23558163 · one of two readings recorded this

  • fatal coronary heart disease events, cohort studies

    increases, 1.32 (1.13 to 1.53)

    Not recorded as a finding: no node for coronary heart disease mortality (coronary-heart-disease-incidence is fatal and non-fatal events)

    The meta-analysis of three studies with five comparisons of sodium intake and coronary heart disease mortality detected an increased risk of fatal coronary heart disease events with higher sodium intake (1.32, 1.13 to 1.53).

    PMID 23558163 · one of two readings recorded this

  • glomerular filtration rate

    no effect

    Glomerular filtration rate (mL/min/1.73 m2) | 1 | 78 | NA | −5.00 (−15.25 to 5.25)

    PMID 23558163 · one of two readings recorded this

  • plasma adrenaline

    no effect

    Plasma adrenaline (pg/mL) | 4 | 168 | 0 | 6.90 (−2.17 to 15.96)

    PMID 23558163 · one of two readings recorded this

  • plasma noradrenaline

    no effect

    Plasma noradrenaline (pg/mL) | 7 | 265 | 32 | 8.23 (−27.84 to 44.29)

    PMID 23558163 · one of two readings recorded this

  • protein:creatinine ratio

    decreases

    Protein:creatinine ratio (mg protein:mmol creatinine) | 1 | 198 | NA | −0.40 (−0.73 to −0.07)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    resting diastolic blood pressure by 1.54 mm Hg (0.98 to 2.11)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    reducing sodium intake decreased resting diastolic blood pressure by 0.87 mm Hg (0.14 to 1.60 mm Hg)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    systolic blood pressure by 3.14 mm Hg (0.30 to 5.98 mm Hg) and diastolic blood pressure by 1.70 mm Hg (0.33 to 3.07 mm Hg)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    no effect

    a non-significant decrease in systolic blood pressure of 8.00 mm Hg (−1.73 to 17.73 mm Hg) and diastolic blood pressure of 4.00 mm Hg (−1.58 to 9.58 mm Hg)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    systolic blood pressure by 3.47 mm Hg (0.76 to 6.18 mm Hg) and diastolic blood pressure by 1.81 mm Hg (0.54 to 3.08 mm Hg) when sodium intake was <2 g/day compared with ≥2 g/day

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    no effect

    <1.2 | 3 | 209 | 0 | −6.39 (−9.53 to −3.25) | 65 | −2.47 (−5.86 to 0.92)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    <2 | 16 | 2415 | 68 | −3.39 (−4.69 to −2.09) | 71 | −1.54 (−2.46 to −0.63)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    Automatic | 17 | 1678 | 3 | −4.04 (−5.10 to −2.97) | 33 | −1.75 (−2.54 to −0.95)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    no effect

    Combination home** | 1 | 16 | NA | −9.00 (−18.32 to 0.32) | NA | −1.00 (−5.44 to 3.44)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    no effect

    Combination office¶ | 1 | 16 | NA | −7.00 (−14.84 to 0.84) | NA | −1.00 (−6.00 to 4.00)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    Crossover | 22 | 2849 | 63 | −4.04 (−5.27 to −2.81) | 54 | −1.70 (−2.43 to −0.97)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    no effect

    Mixed or not specified | 6 | 419 | 27 | −1.67 (−3.01 to −0.34) | 58 | −0.45 (−1.93 to 1.03)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    Hypertension | 24 | 2273 | 13 | −4.06 (−5.15 to −2.96) | 29 | −2.26 (−3.02 to −1.50)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    Male§ | 2 | 53 | 0 | −9.10 (−16.63 to −1.57) | 0 | −4.83 (−8.98 to −0.68)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    Manual | 19 | 5048 | 76 | −2.93 (−4.15 to −1.71) | 70 | −1.40 (−2.18 to −0.62)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    Mixed | 34 | 6749 | 65 | −3.34 (−4.25 to −2.42) | 60 | −1.50 (−2.07 to −0.94)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    no effect

    No hypertension | 7 | 3067 | 61 | −1.38 (−2.74 to −0.02) | 38 | −0.58 (−1.29 to 0.14)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    Not taking drugs | 27 | 5456 | 71 | −3.66 (−4.85 to −2.47) | 62 | −1.70 (−2.37 to −1.04)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    Parallel | 16 | 4147 | 44 | −2.47 (−3.51 to −1.43) | 52 | −1.33 (−2.04 to −0.62)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    <1/3 of control | 8 | 3995 (4001) | 46 | −1.45 (−2.29 to −0.60) | 38 | −0.74 (−1.28 to −0.19)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    Seated office | 18 | 5542 | 76 | −2.91 (−3.99 to −1.82) | 74 | −1.38 (−2.07 to −0.68)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    Standing office | 8 | 705 | 0 | −4.44 (−6.92 to −1.96) | 0 | −1.86 (−3.34 to −0.38)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    Supine office | 15 | 1127 | 0 | −4.69 (−6.33 to −3.06) | 0 | −2.03 (−3.03 to −1.03)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    Taking drugs | 6 | 927 | 9 | −4.55 (−6.59 to −2.51) | 6 | −2.05 (−3.19 to −0.91)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    3-6 | 5 | 2817 | 67 | −1.91 (−3.60 to −0.23) | 67 | −1.33 (−2.50 to −0.15)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    decreases

    <3 | 31 | 3351 | 51 | −4.07 (−5.12 to −3.02) | 49 | −1.67 (−2.33 to −1.02)

    PMID 23558163 · one of two readings recorded this

  • resting diastolic blood pressure

    no effect

    >6 | 3 | 2862 | 59 | −0.88 (−2.00 to 0.23) | 56 | −0.45 (−1.25 to 0.34)

    PMID 23558163 · one of two readings recorded this

  • resting systolic and diastolic blood pressure, randomised trials of reduced versus higher sodium intake

    decreases, systolic -3.39 mm Hg (95% CI 2.46 to 4.31); diastolic -1.54 mm Hg (0.98 to 2.11)

    Not recorded as a finding: comparator is a higher sodium intake (dose against dose), and blood pressure acquisition setting is mixed across trials

    The meta-analysis of 36 studies contributing 49 comparisons found that a reduction in sodium intake significantly reduced resting systolic blood pressure by 3.39 mm Hg (95% confidence interval 2.46 to 4.31 mm Hg) (fig 2) and resting diastolic blood pressure by 1.54 mm Hg (0.98 to 2.11).

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    a reduction in sodium intake significantly reduced resting systolic blood pressure by 3.39 mm Hg (95% confidence interval 2.46 to 4.31 mm Hg)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    reducing sodium intake decreased resting systolic blood pressure by 0.84 mm Hg (0.25 to 1.43 mm Hg)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    a significant reduction in systolic blood pressure of 0.71mm Hg (0.07 to 1.35 mm Hg) was detected

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    no effect

    the reduction in blood pressure was no longer significant (0.62 mm Hg, −0.25 to 1.5 mm Hg)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    systolic blood pressure by 3.14 mm Hg (0.30 to 5.98 mm Hg) and diastolic blood pressure by 1.70 mm Hg (0.33 to 3.07 mm Hg)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    no effect

    a non-significant decrease in systolic blood pressure of 8.00 mm Hg (−1.73 to 17.73 mm Hg) and diastolic blood pressure of 4.00 mm Hg (−1.58 to 9.58 mm Hg)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    systolic blood pressure by 3.47 mm Hg (0.76 to 6.18 mm Hg) and diastolic blood pressure by 1.81 mm Hg (0.54 to 3.08 mm Hg) when sodium intake was <2 g/day compared with ≥2 g/day

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    <1.2 | 3 | 209 | 0 | −6.39 (−9.53 to −3.25) | 65 | −2.47 (−5.86 to 0.92)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    <2 | 16 | 2415 | 68 | −3.39 (−4.69 to −2.09) | 71 | −1.54 (−2.46 to −0.63)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    Automatic | 17 | 1678 | 3 | −4.04 (−5.10 to −2.97) | 33 | −1.75 (−2.54 to −0.95)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    no effect

    Combination home** | 1 | 16 | NA | −9.00 (−18.32 to 0.32) | NA | −1.00 (−5.44 to 3.44)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    no effect

    Combination office¶ | 1 | 16 | NA | −7.00 (−14.84 to 0.84) | NA | −1.00 (−6.00 to 4.00)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    Crossover | 22 | 2849 | 63 | −4.04 (−5.27 to −2.81) | 54 | −1.70 (−2.43 to −0.97)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    Mixed or not specified | 6 | 419 | 27 | −1.67 (−3.01 to −0.34) | 58 | −0.45 (−1.93 to 1.03)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    Hypertension | 24 | 2273 | 13 | −4.06 (−5.15 to −2.96) | 29 | −2.26 (−3.02 to −1.50)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    Male§ | 2 | 53 | 0 | −9.10 (−16.63 to −1.57) | 0 | −4.83 (−8.98 to −0.68)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    Manual | 19 | 5048 | 76 | −2.93 (−4.15 to −1.71) | 70 | −1.40 (−2.18 to −0.62)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    Mixed | 34 | 6749 | 65 | −3.34 (−4.25 to −2.42) | 60 | −1.50 (−2.07 to −0.94)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    No hypertension | 7 | 3067 | 61 | −1.38 (−2.74 to −0.02) | 38 | −0.58 (−1.29 to 0.14)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    Not taking drugs | 27 | 5456 | 71 | −3.66 (−4.85 to −2.47) | 62 | −1.70 (−2.37 to −1.04)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    Parallel | 16 | 4147 | 44 | −2.47 (−3.51 to −1.43) | 52 | −1.33 (−2.04 to −0.62)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    <1/3 of control | 8 | 3995 (4001) | 46 | −1.45 (−2.29 to −0.60) | 38 | −0.74 (−1.28 to −0.19)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    Seated office | 18 | 5542 | 76 | −2.91 (−3.99 to −1.82) | 74 | −1.38 (−2.07 to −0.68)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    Standing office | 8 | 705 | 0 | −4.44 (−6.92 to −1.96) | 0 | −1.86 (−3.34 to −0.38)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    Supine office | 15 | 1127 | 0 | −4.69 (−6.33 to −3.06) | 0 | −2.03 (−3.03 to −1.03)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    Taking drugs | 6 | 927 | 9 | −4.55 (−6.59 to −2.51) | 6 | −2.05 (−3.19 to −0.91)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    3-6 | 5 | 2817 | 67 | −1.91 (−3.60 to −0.23) | 67 | −1.33 (−2.50 to −0.15)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    decreases

    <3 | 31 | 3351 | 51 | −4.07 (−5.12 to −3.02) | 49 | −1.67 (−2.33 to −1.02)

    PMID 23558163 · one of two readings recorded this

  • resting systolic blood pressure

    no effect

    >6 | 3 | 2862 | 59 | −0.88 (−2.00 to 0.23) | 56 | −0.45 (−1.25 to 0.34)

    PMID 23558163 · one of two readings recorded this

  • serum creatinine

    no effect

    Serum creatinine (µmol/L) | 5 | 728 | 0 | 1.68 (−0.65 to 4.00)

    PMID 23558163 · one of two readings recorded this

  • stroke, all events

    increases

    All events21 22 100-104 106 107 | 10 | 72 878 | 49 | 1.24 (1.08 to 1.43)

    PMID 23558163 · one of two readings recorded this

  • stroke, combined fatal and non-fatal events

    increases

    Combined fatal and non-fatal events21 22 100-103 106 | 8 | 28 974 | 20 | 1.13 (1.01 to 1.26)

    PMID 23558163 · one of two readings recorded this

  • stroke, fatal events

    increases

    Fatal events101 104 107 | 3 | 48 645 | 33 | 1.63 (1.27 to 2.10)

    PMID 23558163 · one of two readings recorded this

  • total cholesterol

    no effect

    Total cholesterol (mmol/L) | 11 | 2339 | 0 | 0.02 (−0.03 to 0.07)

    PMID 23558163 · one of two readings recorded this

  • urinary adrenaline (epinephrine)

    no effect

    Urinary adrenaline (epinephrine, pg/mL) | 1 | 18 | NA | −13.10 (−29.24 to 3.04)

    PMID 23558163 · one of two readings recorded this

  • urinary noradrenaline (norepinephrine)

    no effect

    Urinary noradrenaline (norepinephrine, pg/mL) | 2 | 53 | 0 | 17.13 (−34.06 to 68.33)

    PMID 23558163 · one of two readings recorded this

  • urinary protein excretion

    no effect

    Urinary protein excretion (µmol/L) | 1 | 198 | NA | −76.61 (−154.20 to 0.97)

    PMID 23558163 · one of two readings recorded this

  • resting blood pressure

    no effect, n = 70

    Diet did not affect resting blood pressure

    PMID 24284498 · one of two readings recorded this

  • resting heart rate

    decreases, p = 0.02, n = 70

    heart rate (HR) (mean ± SE) was 66 ± 1, 64 ± 1, and 63 ± 1 bpm in low, normal, and high sodium conditions, respectively (analysis of variance P = 0.02)

    PMID 24284498 · one of two readings recorded this

  • resting HRV: LFnu increase and SDNN, RMSSD, HFnu decrease, low vs normal and high sodium

    modulates, p = 0.05, n = 70

    with increased LFnu and decreased SDNN, RMSSD, and HFnu compared to both normal and high sodium conditions (P ≤0.05 for all)

    PMID 24284498 · one of two readings recorded this

  • resting HRV: SDNN, RMSSD, high frequency, LFnu and HFnu, main effect of sodium

    modulates, p = 0.01, n = 70

    high frequency, low-frequency normalized units (LFnu), and high-frequency normalized units (HFnu) (P < 0.01 for all)

    PMID 24284498 · one of two readings recorded this

  • sodium-by-mental stress interaction on mean NN, RMSSD, high-frequency power, LFnu and LF/HF ratio

    modulates, p = 0.05, n = 70

    Dietary sodium-by-mental stress interactions were significant for mean NN, RMSSD, high-frequency power, LFnu, and low frequency/high frequency ratio (P < 0.05 for all)

    PMID 24284498 · one of two readings recorded this

The whole record — 971 rows